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Immunity against the bovine intracellular protozoan parasite Theileria parva has been shown to be mediated
by CD8 T cells. Six antigens targeted by CD8 T cells from T. parva-immune cattle of different major histo-
compatibility complex (MHC) genotypes have been identified, raising the prospect of developing a subunit
vaccine. To facilitate further dissection of the specificity of protective CD8 T-cell responses and to assist in the
assessment of responses to vaccination, we set out to identify the epitopes recognized in these T. parva antigens
and their MHC restriction elements. Nine epitopes in six T. parva antigens, together with their respective MHC
restriction elements, were successfully identified. Five of the cytotoxic-T-lymphocyte epitopes were found to be
restricted by products of previously described alleles, and four were restricted by four novel restriction
elements. Analyses of CD8 T-cell responses to five of the epitopes in groups of cattle carrying the defined
restriction elements and immunized with live parasites demonstrated that, with one exception, the epitopes
were consistently recognized by animals of the respective genotypes. The analysis of responses was extended to
animals immunized with multiple antigens delivered in separate vaccine constructs. Specific CD8 T-cell
responses were detected in 19 of 24 immunized cattle. All responder cattle mounted responses specific for
antigens for which they carried an identified restriction element. By contrast, only 8 of 19 responder cattle
displayed a response to antigens for which they did not carry an identified restriction element. These data
demonstrate that the identified antigens are inherently dominant in animals with the corresponding MHC
genotypes.
Major histocompatibility complex (MHC) class I-restricted
CD8 T-cell responses have been shown to play an important
role in the immune response against a number of protozoan
infections, including Plasmodium spp. (3, 22) and Theileria spp.
(14) infections. Theileria parva causes an often fatal lympho-
proliferative disease of cattle known as East Coast fever (16).
Like Plasmodium spp., T. parva initially infects and replicates
in nucleated cells, after which it invades erythrocytes. How-
ever, the ability of T. parva to transform host lymphocytes and
undergo rapid multiplication in the transformed cells, as well
as the limited replicative capacity of the intraerythrocytic pi-
roplasm stage, represent fundamental differences from the cor-
responding plasmodial stages. Cattle that recover from an ini-
tial exposure to T. parva, either spontaneously or as a result of
chemotherapy, are solidly immune to homologous and, in cer-
tain instances, heterologous challenge (17). The long duration
of immunity to East Coast fever also contrasts with immu-
nity to malaria, which develops only after several years of
exposure and wanes in the absence of exposure to parasite
challenge (9). The ability to culture the schizont stage of the
parasite in continuously growing lymphoblastoid cell lines
allows detailed in vitro analyses of T-cell responses to the
whole parasite; this system has been used extensively to
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monitor responses in animals undergoing immunization and
challenge and to examine the specificity of the responses (6,
7, 8, 10, 11, 15, 19, 20).
Evidence that immunity to T. parva is mediated by MHC
class I-restricted CD8 T cells specific for the intralymphocytic
schizont stage of the parasite is based on observations on the
kinetics of CD8 T-cell responses (15) and the demonstration
that immunity can be transferred adoptively with CD8 T-cell-
enriched populations from immune cattle (13). Parasite-spe-
cific CD8 T-cell responses induced by immunization with a
single parasite strain show differential degrees of recognition
of heterologous parasite strains, and a close correlation be-
tween the specificity of CD8 T-cell responses and the cross-
immunity profiles of distinct parasite strains has been observed
previously (8, 19). Analyses of CD8 T-cell responses of cattle
of defined MHC genotypes have suggested that strain speci-
ficity is due, in part, to the focusing of the responses of indi-
vidual animals on a limited number of immunodominant pep-
tides and MHC determinants (8, 19).
Recently, six T. parva antigens recognized by CD8 T cells
have been identified using CD8 T-cell lines from immune cat-
tle to screen a parasite cDNA library and a set of cDNAs
selected on the basis of bioinformatic analyses of the parasite
genome (10, 11). All but one of the CD8 T-cell lines used for
screening identified a single antigen, and lines from cattle of
different MHC genotypes tended to identify different antigens.
Additional analyses of a number of these target antigens have
demonstrated that they are polymorphic (R. Pelle´, unpub-
lished data). The identification of schizont antigens provides
an opportunity not only to explore vaccination, but also to
dissect further the specificity of CD8 T-cell responses in order
to understand better the basis of the strain specificity of im-
munity to T. parva. Here, we report the identification of anti-
genic epitopes in the six CD8 T-cell target antigens and their
MHC restriction specificities. By examining responses of cattle
to immunization with live parasites or a cocktail of the CD8
T-cell target antigens, we also provide evidence that these
antigens are highly dominant in animals with the correspond-
ing MHC genotypes.
MATERIALS AND METHODS
Cattle and cell lines. All animal experimentation procedures were reviewed
and approved by the International Livestock Research Institute (ILRI) Institu-
tional Animal Care and Use Committee or the United Kingdom Home Office.
Boran (Bos indicus), Jersey (Bos taurus), Holstein-Friesian (Bos taurus), and
crossbred cattle with no prior exposure to T. parva were recruited for the study.
Cattle of defined MHC genotypes were included. MHC class I types were
determined using a combination of serological typing with alloantisera (21)
and/or monoclonal antibodies (5) and allele-specific PCR (4). Most of the ani-
mals expressing one of three fully defined class I haplotypes (B. taurus A10 and
A18 and B. indicus A10-KN104) were the progeny of bulls known to carry these
haplotypes, and this group included several animals produced by father-daughter
mating that were homozygous for the MHC type. For experiments involving the
immunization of cattle with T. parva antigens, the expression of specific class I
alleles was also confirmed functionally by testing the ability of cells from indi-
vidual typed animals to present peptide to CD8 T-cell lines of the appropriate
MHC restriction specificity. Lymphoblasts obtained by the stimulation of periph-
eral blood mononuclear cells with concanavalin A (Sigma, Poole, United King-
dom) (6) were pulsed with titration preparations of antigenic peptides for 1 h at
37°C and then fixed in 0.1% glutaraldehyde as described previously (12). Cells
(2.5  104/well) were cocultured with antigen-specific CD8 T-cell lines, and
recognition was assessed by a gamma interferon (IFN-) enzyme-linked immu-
nospot (ELISPOT) assay (10).
Cattle were immunized against the T. parva Muguga stock by the infection-
and-treatment method and then challenged after 3 months with the same para-
site stock described previously (19). T. parva-specific polyclonal CD8 T-cell lines
and clones were established from the peripheral blood of immunized animals by
repeated restimulation with irradiated autologous infected lymphoblasts as pre-
viously described (6). After three rounds of in vitro restimulation, CD8 T cells
were purified by magnetic cell sorting with a MACS system according to the
instructions of the manufacturer (Miltenyi Biotec, Gergisch Gladbach, Ger-
many). CD8 T cells were sorted indirectly using a monoclonal antibody specific
for bovine CD8 (IL-A105; ILRI, Nairobi, Kenya), followed by incubation with
goat anti-mouse immunoglobulin G microbeads (Miltenyi Biotec). CD8 T cells
were maintained in RPMI 1640 medium supplemented with 10% fetal bovine
serum (tested for bovine viral diarrhea virus and Mycoplasma spp.; Perbio Sci-
ence UK, Ltd., Cramlington, United Kingdom), 10 U of recombinant human
interleukin-2 (Sigma)/ml, 100 IU of penicillin/ml, 100 g of streptomycin/ml, 50
g of gentamicin/ml, 5 105 M 2-mercaptoethanol, and 2 mM L-glutamine and
were stimulated every 14 days with irradiated autologous T. parva-infected lym-
phoblasts at a responder-to-stimulator ratio between 2:1 and 10:1 (6). The
specificities of the CD8 T-cell lines were assessed using a chromium-51 release
assay (6). CD8 T-cell lines were harvested 6 to 8 days poststimulation and
cocultured for 4 h with chromium-51 (Amersham)-labeled T. parva-infected
lymphoblasts, peptide-pulsed skin fibroblasts, or transfected COS-7 cells (10).
The degree of lysis of target cells was calculated as follows: % lysis  100  (test
release  spontaneous release)/(maximum release  spontaneous release).
Alternatively, CD8 T-cell specificity was assessed by measuring the release of
IFN- by an ELISPOT assay (10) or, in limited instances, by a bioassay (1). CD8
T cells were harvested 7 to 14 days poststimulation and resuspended at 2 
105/ml in RPMI 1640 medium supplemented with 10% fetal bovine serum and 5
U of recombinant human interleukin-2 (Sigma)/ml and were cocultured with
autologous immortalized skin fibroblasts or COS-7 cells pulsed with synthetic
peptides or transfected with plasmids expressing parasite antigens. Experiments
directed at epitope mapping and the identification of MHC class I restriction
elements utilized CD8 T cells from eight cattle, including the cell lines and the
clone used previously to identify the six T. parva antigens (Table 1; 10). The
generation of the clonal CD8 T-cell line from animal D409 was described pre-
viously (8).
T. parva antigens. Six T. parva antigens, Tp1, Tp2, Tp4, Tp5, Tp7, and Tp8,
previously identified to be the targets of CD8 T-cell responses of T. parva-
immune cattle, were used in this study (Table 1) (10). cDNA corresponding to
the full-length open reading frame (ORF) for Tp2 was cloned into the eukaryotic
expression plasmid vector pTargeT (Promega, Madison, WI), while the full-
length ORFs for Tp1, Tp4, and Tp5 were cloned into the eukaryotic expression
plasmid vector pcDNA3 (Invitrogen, Paisley, United Kingdom) (10). Partial
cDNAs encoding amino acids 1 to 291 of the 721 amino acid residues of Tp7 and
all but the first 22 amino acid residues of Tp8 were also cloned into pcDNA3.
Cloning and functional screening of BoLA class I cDNA. mRNA was purified
from bovine peripheral blood mononuclear cells by using the mRNA DIRECT
kit (Dynal Biotech, Oslo, Norway). Reverse transcriptase PCR was conducted
using degenerate primers designed with sequences from the partially conserved
regions of published bovine leukocyte antigen (BoLA) class I cDNA sequences
(5-ATG[A/G]GGCCGCGA[A/G]CCC[T/A]-3 and 5-TCA[A/C][A/G]CTTTA
GGAAC[C/T][G/A]TG[A/C]G-3). PCR products were cloned into pTargeT
(Promega), and orientation was confirmed by PCR with a T7 forward primer and
a pan-BoLA class I gene reverse primer (5-CCAGGTATCTGCGGAGCC-3).
Plasmid DNA from all positive clones was purified with a QIAprep Spin mini-
prep kit (QIAGEN, Crawley, United Kingdom), and aliquots of 50 ng/well were
used to transfect 2  104 COS-7 cells/well in 96-well flat-bottom plates. Twenty-
four hours posttransfection, COS-7 cells were detached and the surface expres-
sion of BoLA class I was assessed by staining with a pan-BoLA class I mono-
clonal antibody (IL-A88; ILRI, Nairobi, Kenya) (5) and analysis by flow
cytometry using a FACScan (Becton Dickinson, Sunnyvale, CA). COS-7 cells
were cotransfected with positive cDNA clones (100 ng/well) and the appropriate
CD8 T-cell target antigen cDNA (100 ng/well), and the recognition of transfec-
tants by CD8 T-cell lines was assessed by an IFN- ELISPOT assay as described
previously (10). For cytotoxicity assays, COS-7 cells transfected with BoLA and
CD8 T-cell target antigen cDNAs and T. parva-infected cells were labeled with
chromium-51 (Amersham Biosciences Europe GmbH, Freiburg, Germany) and
lysis by parasite-specific T-cell lines was assessed by measuring isotope release
after incubation for 4 h at 37°C (6).
Mapping and identification of antigenic peptides. Exonuclease III digestion
was used to generate truncated cDNA clones to assist in mapping the epitope-
encoding region of the Tp1 gene. Recombinant Tp1 plasmid DNA was digested
with ApaI to generate exonuclease III-resistant protruding 3 termini. The lin-
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earized plasmid DNA was purified by phenol-chloroform extraction and digested
with XhoI, which cut at a unique vector cloning site to generate exonuclease
III-sensitive recessed 3 termini. The linearized DNA was purified as described
above, and 100-ng aliquots were digested with 1 U of exonuclease III (New
England BioLabs, Beverly, MA) in 20-l reaction mixtures at 37°C for various
times (from 0 to 30 min). Reactions were stopped by 10 min of incubation at
75°C. DNA was ethanol precipitated, washed with 70% ethanol, air dried, and
redissolved in 20 l of 1 Mung Bean nuclease reaction buffer (New England
BioLabs). Five units of Mung Bean nuclease was added to each reaction mixture,
and the mixtures were incubated at 30°C for 1 h to remove single-stranded DNA
extensions and create blunt ends that could be ligated. The DNA was purified,
precipitated, washed, and dissolved in 10 l of sterile distilled water. For re-
ligation, 5 l of DNA was mixed with 1 l of 10 T4 DNA ligase buffer, 3 l of
water, and 1 l of T4 DNA ligase (New England BioLabs) and the mixture was
incubated at 16°C overnight. Competent Escherichia coli DH5 cells were then
transformed with 2 l of the ligation mixture, plated onto agar plates containing
ampicillin, and grown overnight. Plasmid DNA from single bacterial colonies was
purified by using the Wizard Plus SV miniprep DNA purification kit (Promega),
and inserts were excised by digestion with BamHI and NotI. Plasmid clones with
cDNA inserts of different sizes were selected for IFN- ELISPOT screening.
Oligonucleotide primers were designed to allow the amplification of three over-
lapping fragments of a 387-bp region of Tp1 cDNA, six overlapping fragments of
Tp4 cDNA, four overlapping fragments of Tp7 cDNA, and six overlapping
fragments of Tp8 cDNA, which were cloned into pTargeT (Promega) (see Fig.
1). The recognition of the truncated subclones by CD8 T-cell lines was then
analyzed by an IFN- ELISPOT assay. Synthetic overlapping peptides spanning
the entire lengths of Tp2 (12-mers offset by two residues) and Tp5 (11-mers offset
by two residues) and a defined epitope-containing region of Tp1 (12-mers offset
by two residues) were obtained from Mimotopes (Clayton, Australia), while
peptides spanning epitope-containing regions of Tp4, Tp7, and Tp8 (15-mers
offset by four residues) were obtained from Pepscan Systems B.V. (Lelystad, The
Netherlands). Peptides were dissolved in a solution of 50% (vol/vol) DNA
synthesis-grade acetonitrile-water (Applied Biosystems, Warrington, United
Kingdom), aliquoted, and stored at 20°C.
Autologous immortalized skin fibroblasts (10) were cocultured with parasite-
specific CD8 T cells in the presence of peptides at a concentration of 1 g/ml,
and recognition was assessed by an IFN- ELISPOT assay. Based on the se-
quences of positive overlapping peptides, individual 8-, 9-, 10-, and 11-mer
peptides were synthesized, and titration preparations of peptides were tested
using an IFN- ELISPOT assay. To test for cytotoxic activity, immortalized skin
fibroblasts were pulsed overnight with peptides at a concentration of 1 g/ml and
labeled with chromium-51 (Amersham) and the degree of lysis by CD8 T-cell
lines was measured (6).
Assessment of the specificity of CD8 T-cell responses following heterologous
primer-booster immunization of cattle with recombinant plasmid DNA and
viruses. Recombinant pSG2 DNA vaccine plasmids, canary pox (CP) virus, and
the modified vaccinia virus Ankara strain (MVA) expressing Tp1, Tp2, Tp4, Tp5,
and Tp8 ORFs were used in a heterologous primer-booster regimen to immunize
calves that had been identified as expressing a BoLA class I allele capable of
presenting one or more of the defined antigens to CD8 T cells (10). The recom-
binant DNA, CP virus, and MVA constructs expressing the five single antigens
were prepared separately and inoculated at different sites on each animal. Cattle
were primed with 0.5 mg of each recombinant DNA plasmid by intradermal
injection or with 108 PFU of each recombinant CP virus by subcutaneous injec-
tion. After 4 weeks, cattle were inoculated subcutaneously with 5  108 PFU of
each MVA recombinant. Control calves received sham inoculations with phos-
phate-buffered saline. Three weeks after the MVA booster, cattle were chal-
lenged with a lethal dose of T. parva sporozoites (1:20 dilution of T. parva
Muguga stock sporozoite stabilate no. 4133; ILRI, Nairobi, Kenya). Purified
CD8 T cells (2.5  105/well) and monocytes (2.5  104/well) were cocultured
with pools of overlapping synthetic peptides (at a 1-g/ml final concentration)
covering the entire antigens (Tp2 12-mers offset by two residues [Mimotopes],
Tp5 11-mers offset by two residues [Mimotopes], and Tp1, Tp4, and Tp8 16-mers
offset by four residues [Pepscan Systems]), and responses were measured by an
IFN- ELISPOT assay (10). Responses were classified as antigen specific when
the number of spot-forming cells (SFC) in wells containing peptide was three
times greater than that obtained with T cells in medium alone. For all responses,
the number of SFC among peptide-stimulated cells was 	2 standard deviations
(95% confidence interval) above the mean number of SFC among unstimulated
cells.
Statistical analysis. An analysis of variance for the evaluation of fixed effects
on different traits was performed by using SAS Release 8.2 (SAS Institute Inc.,
Cary, NC).
Nucleotide sequence accession numbers. The nucleotide sequences of the
BoLA class I cDNAs for T2c, T5, and T7 have been deposited in GenBank under
accession numbers EU189194, EU189195, and EU189196, respectively.
RESULTS
Identification of epitopes on T. parva antigens recognized
by CD8 T cells. A two-step approach to the identification of the
CD8 T-cell epitopes on T. parva antigens was adopted, utilizing
CD8 T-cell lines from T. parva-immune animals in an IFN-
ELISPOT assay. The first step employed a molecular approach
to map the epitope-containing regions, and the second step
involved the screening of overlapping synthetic peptides for
fine mapping and definition of the antigenic peptides. Due to
their small size, Tp2 and Tp5 were omitted from the first step
and peptides spanning the entire proteins were utilized.
Screening for CD8 T-cell recognition of autologous immor-
talized skin fibroblasts transfected with cDNA clones encoding
segments of antigens Tp1, Tp4, Tp7, and Tp8 identified regions
TABLE 1. Summary of CD8 T-cell target T. parva antigens and cattle from which antigen-specific CD8 T-cell lines were generated
Antigen







MHC class I serotype of
donor animald
Tp1 XP_762973 543 Hypothetical protein BV115 A10/A18




Tp4 XP_763228 579 ε-TCP1 BX063 A10-KN104f
Tp5 XP_765334 155 eIF-1A BV050 /
Tp7 XP_764810 721 Hsp90 BW012 /
Tp8 XP_764709 440 Cysteine proteinase BX063 A10-KN104f
a The size of the full-length protein predicted by each gene sequence is given.
b Abbreviations: ε-TCP1, eta subunit of T complex protein 1; eIF-1A, translation elongation initiation factor 1A; Hsp90, heat shock protein 90.
c Parasite-specific polyclonal CD8 T-cell lines were generated from cattle following infection-and-treatment immunization and challenge.
d MHC class I type determined on the basis of parentage and the reactivity of cells with monoclonal antibodies. Minus signs denote unknown haplotypes.
e A parasite-specific CD8 T-cell clone was isolated from this animal (8).
f Homozygous MHC serotype.
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encoding antigenic peptides (Fig. 1). For one of the antigens,
Tp1, a set of four truncated cDNA clones that had been di-
gested to various lengths by exonuclease III and Mung Bean
nuclease was used. Screening of these clones with a Tp1-spe-
cific CD8 T-cell line showed that the antigenic peptide(s) lay
between amino acid residues 192 and 241. The presence of an
epitope(s) in this region was confirmed by screening a further
three overlapping cDNA subclones spanning the correspond-
ing part of the gene. Sets of sequential overlapping cDNA
clones were used to locate the epitope-containing regions in a
further three antigens, Tp4, Tp7, and Tp8. In the case of Tp7,
these clones corresponded to the first 291 amino acids of the
protein (full length, 721 amino acids), as the original cDNA
clone identified by the screening of a parasite cDNA library
with CD8 T cells encodes only this part of the protein (10). The
screening of sets of six, four, and three overlapping fragments
of Tp4, Tp7, and Tp8 cDNAs, respectively, with the respec-
tive specific CD8 T-cell lines established the epitope-con-
taining regions as amino acids 296 to 409 of Tp4 (Tp4296–409),
Tp7145–224, and Tp8294–440. The screening of a further three
short overlapping cDNA clones corresponding to residues 294
to 440 of Tp8 further resolved the epitope-containing region to
Tp8338–394.
Libraries of overlapping synthetic peptides covering the de-
fined epitope-containing regions of Tp1, Tp4, Tp7, and Tp8,
along with the entire lengths of Tp2 and Tp5, were screened to
determine the sites of the epitopes. Three polyclonal CD8
T-cell lines and one cloned antigen-specific CD8 T-cell line,
derived from different cattle, were used to screen the Tp2
antigen, whereas a single polyclonal T-cell line was used for
each of the other antigens. CD8 T-cell reactivity against two
overlapping peptides of Tp1, Tp4, Tp5, and Tp7 and against
three overlapping Tp8 peptides was observed (data not
shown). The four CD8 T-cell lines used to screen Tp2 peptides
identified four distinct epitope-containing sites (data not
shown).
The minimal-length antigenic peptide that gave maximal
CD8 T-cell reactivity was determined for each antigenic site by
screening titration preparations of shorter peptides spanning
the epitope-containing regions with an IFN- ELISPOT assay
(Fig. 2). This screening resulted in the identification of the
minimal-length antigenic peptides as the 11-mer Tp1214–224
(VGYPKVKEEML; P 
 0.01) and the 9-mers Tp4328–336 (T
GASIQTTL; P 
 0.01), Tp587–95 (SKADVIAKY; P 
 0.01),
Tp7206–214 (EFISFPISL; P 
 0.01), and Tp8379–387 (CGAEL
NHFL; P 
 0.01) (Fig. 2). The Tp2-specific CD8 T cells from
animals BW002, BW013, D409, and BW014 identified two
11-mers, Tp227–37 (SHEELKKLGML) and Tp249–59 (KSSHG
MGKVGK), and two 9-mers, Tp296–104 (FAQSLVCVL) and
Tp298–106 (QSLVCVLMK), respectively (P 
 0.01) (Fig. 2).
The ability of the nine identified minimal-length antigenic
peptides to elicit cytotoxic activity in specific CD8 T-cell lines
was examined using autologous immortalized skin fibroblasts
pulsed with peptide, and the resultant cytotoxicity was com-
pared with that obtained using parasitized cells as targets (Fig.
3). In all cases, the degree of lysis of peptide-pulsed cells was
greater than (for T-cell lines from animals BV115 [Tp1214–224],
BW014 [Tp298–106], BV050 [Tp587–95], and BX063 [Tp8379–387])
or comparable to (for T-cell lines from animals BW002
[Tp227–37], BW013 [Tp249–59], D409 [Tp296–104], BX063
[Tp4328–336], and BW012 [Tp7206–214]) that of infected cells,
further indicating that these peptide sequences are likely to
represent the natural epitopes (P 
 0.01).
Identification of BoLA restriction of CD8 T-cell epitopes on
T. parva antigens. Only a few of the MHC class I genes ex-
pressed by the animals used in these experiments had been
identified at the outset of the studies (10). The B. taurus hap-
lotype carrying the serologically defined class I specificity A18
was known to express a single class I gene, N*01301, and this
gene had been used in the antigen-screening protocol that
resulted in the identification of Tp1. A second haplotype,
found in B. indicus cattle, carries the A10 and KN104 serolog-
ical specificities, which are encoded by the N*00101 and
N*00301 class I genes, respectively; these genes were also used
in the antigen-screening protocol that identified the Tp4 and
Tp8 antigens. Subsequent experiments involving cotransfec-
tion with the class I and antigen genes demonstrated that both
Tp4 and Tp8 are presented by the N*00101 gene product. The
recognition of the epitopes identified in Tp1, Tp4, and Tp8
in the context of these class I molecules was confirmed by
testing COS-7 cells transfected with the individual class I
genes and CD8 target antigen cDNAs in an IFN- ELISPOT
assay (Fig. 4).
The MHC restriction specificities of antigen recognition by
FIG. 1. Mapping of CD8 T-cell epitopes on defined T. parva antigens.
The recognition of autologous immortalized skin fibroblasts transiently
transfected with full-length, partial-length, exonuclease III-digested, or
cloned fragments of cDNA encoding Tp1, Tp4, Tp7, and Tp8 by antigen-
specific CD8 T-cell lines (those from animals BV115 [Tp1], BX063 [Tp4
and Tp8], and BW012 [Tp7]) was assessed by an IFN- ELISPOT assay.
The results of one of two independent experiments are shown. The data
are the mean numbers of SFC/104 CD8 T cells for triplicate cultures. The
amino acids included in the antigen peptides are indicated.
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the remaining T-cell lines were determined by isolating a set of
cloned full-length class I MHC heavy-chain cDNAs from each
of the donor animals, cotransfecting COS-7 cells with these
cDNAs and the respective CD8 target antigen cDNAs, and
screening for recognition by antigen-specific CD8 T-cell lines.
The nucleotide sequences of class I cDNAs giving positive
responses were then determined.
Using this approach, we identified class I cDNAs capable of
presenting the antigens for all of the remaining T-cell lines. As
an example, the screening of cDNA clones from animals
BW013 and BW014, which recognized the Tp2 antigen, de-
tected 2 of 17 and 1 of 9 class I cDNA clones, respectively, that
were effective at presenting Tp2 to the antigen-specific CD8
T-cell lines from these animals. All three positive cDNAs were
shown to correspond to the class I allele N*01201 (data not
shown), which is expressed by B. taurus animals carrying the
A10 class I serological specificity; the latter specificity is en-
coded by a second gene of this haplotype (N*00102), which
differs in sequence from the gene encoding A10 (N*00101) in
B. indicus. The four epitopes in Tp2, which had been identified
using T-cell lines from four different cattle, were found to be
restricted by three different class I alleles. Tp249–59 and Tp298–106,
which were identified using T-cell lines from B. taurus A10
animals, were confirmed to be restricted by N*01201; Tp227–37
and Tp296–104 were restricted by two novel alleles, one desig-
nated N*04001 and the other temporarily designated BoLA-
T2c, derived from animals BW002 and BX017, respectively
(Fig. 4). The epitopes identified in Tp5 and Tp7, Tp587–95 and
Tp7206–214, were found to be restricted by two novel alleles,
temporarily designated BoLA-T5 and BoLA-T7, respectively,
derived from animals BV050 and BW012 (Fig. 4). Cytotoxicity
assays were also performed with cells cotransfected with the
identified class I cDNAs and the corresponding CD8 T-cell
target antigen cDNAs, and in all cases the results confirmed
those obtained in the IFN- ELISPOT assay (data not shown).
To determine whether the epitopes identified in the course
of these studies were consistently recognized by CD8 T cells
from animals carrying the respective MHC class I restriction
FIG. 2. Identification of CD8 T-cell epitopes on defined T. parva antigens. Titration preparations of overlapping synthetic peptides were used
to pulse immortalized skin fibroblasts, and the recognition by antigen-specific CD8 T cells (those from animals BV115 [Tp1213–224], BW002
[Tp224–39], BW013 [Tp248–60], D409 [Tp296–106], BW014 [Tp297–107], BX063 [Tp4328–338 and Tp8378–388], BV050 [Tp583–97], and BW012 [Tp7204–214]) was
assessed using an IFN- ELISPOT assay. Minimal-length antigenic peptides were identified as the shortest peptides that induced CD8 T-cell
reactivity at the lowest concentration. The results of one of two independent experiments are shown. The data are the mean numbers of SFC/104
CD8 T cells  standard errors of the means for triplicate cultures.
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elements, analyses of responses were extended to additional T.
parva-immune animals expressing three of the class I alleles,
namely, N*00101, N*01301, and N*01201, associated with the
serological specificities A10-KN104 (B. indicus), A18 (B. tau-
rus), and A10 (B.taurus), respectively. In each instance, these
groups included two or three animals known, on the basis of
typing and breeding records, to be homozygous for the MHC
type. The results are summarized in Table 2. All five A18
animals examined were found to respond to Tp1214–224. Simi-
larly, all five B. taurus A10 animals gave significant responses
to both of the epitopes identified in the Tp2 antigen. Of seven
B. indicus A10-KN104 cattle examined, all gave significant
responses to the Tp8379–387 epitope, but responses to Tp4328–336
were detected in only four animals, three of which were
homozygous for this MHC haplotype. Thus, only one of the
four animals heterozygous for the MHC type recognized
Tp4328–336.
Responses induced by immunization of cattle with a mixture
of T. parva antigens expressed individually in vaccine con-
structs. Access to animals subjected to primer-booster immu-
nization with five of the T. parva antigens by using separate
vaccine constructs for each antigen (10) provided an opportu-
nity to ascertain whether such immunization results in re-
sponses to all of the antigens or only those corresponding to
the MHC alleles expressed by the animals. Four groups of six
cattle, each expressing one of four selected class I alleles
(N*01301, N*01201, N*00101, and T5), were used in these
studies. Within each group, three of the animals were immu-
nized with plasmid DNA preparations and three were immu-
nized with recombinant CP viruses expressing five of the T.
parva antigens (Tp1, Tp2, Tp4, Tp5, and Tp8). After 4 weeks,
all animals received a booster dose of recombinant MVA ex-
pressing the same antigens and were then challenged with T.
parva sporozoites after a further 3 weeks. Specific CD8 T-cell
responses to the five antigens were examined every 7 days by
using pools of overlapping peptides in an IFN- ELISPOT
assay (Table 3). The responses to Tp2 were generally poor,
with only four animals, including two of the six animals carry-
ing the identified restriction element (N*1201), giving signifi-
cant responses. The majority of the animals carrying the iden-
tified class I restriction elements for the remaining four
antigens generated significant responses to the respective an-
tigens. Thus, all six T5 animals responded to Tp5, all
N*01301 animals responded to Tp1, and five of six N*00101
animals responded to both Tp4 and Tp8. By contrast, many of
the animals failed to give significant responses to the antigens
for which they did not carry an identified class I restriction
element. Thus, none of the remaining 18 animals responded to
Tp5, and only one and two N*00101-negative animals re-
sponded to Tp4 and Tp8, respectively. A larger number (6 of
18) of the N*01301-negative animals responded to Tp1. Over-
all, in 11 of the 19 animals that responded to one or more
antigens, the significant response was focused entirely on the
antigen or antigens for which the animal carried the identified
class I restriction element. Moreover, the magnitudes of re-
sponses to antigens for which the animals carried identified
class I restriction elements were in most instances greater than
those of responses to other antigens. To illustrate this finding,
the CD8 T-cell responses of the six BoLA allele N*00101
animals are depicted in Fig. 5. After priming and booster
FIG. 3. CD8 cytotoxic-T-lymphocyte activity against epitope-pulsed immortalized skin fibroblasts and T. parva-infected cells. The lysis of T.
parva-infected cells and peptide-pulsed and unpulsed immortalized skin fibroblasts by antigen-specific cytotoxic T lymphocytes (those from animals
BV115 [Tp1214–224], BW002 [Tp227–37], BW013 [Tp249–59], D409 [Tp296–104], BW014 [Tp298–106], BX063 [Tp4328–336 and Tp8379–387], BV050
[Tp587–95], and BW012 [Tp7206–214]) was evaluated using a
51Cr release assay. The results of one of two independent experiments are shown. The
data are the means  standard errors of the means for triplicate cultures. E:T ratio, effector-to-target cell ratio; TpM, T. parva-infected cells; iSF,
unpulsed immortalized skin fibroblasts; iSF peptide, peptide-pulsed immortalized skin fibroblasts.
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immunizations, responses were dominated by Tp8, with signif-
icant responses to Tp4 also being observed in five of six ani-
mals, although with one exception (that in animal BX225),
these responses were of lesser magnitude than the Tp8-specific
responses. Three animals mounted a response to a third anti-
gen, Tp1, and this Tp1 response was most significant in animal
BX225. Following challenge infection, only one animal,
BX219, showed a clear recall of the responses, although the
peak was below that observed after the MVA booster. The
magnitudes of the responses of the other animals were more
variable than those of the BoLA allele N*00101 animals, but
the evidence of boosting of responses in the N*00101-negative
animals by challenge was clearer, and in most instances, the
hierarchy of dominance was maintained after challenge (data
not shown). This strong association between the expression of
the defined class I restriction element and the antigen speci-
ficity of the CD8 T-cell response indicates that the respective
antigens are inherently dominant antigens in animals with the
corresponding MHC genotypes.
DISCUSSION
Despite the vast pool of potentially antigenic peptides, data
from previous studies of cattle immunized by infection and
treatment suggested that the CD8 T-cell response is restricted
to a limited number of immunodominant antigens (8, 19).
Thus, evidence of a hierarchy in dominance in MHC restric-
tion of the response was obtained; responses were often re-
stricted in their parasite strain specificity and, in animals of
different MHC genotypes, frequently exhibited different pat-
terns of parasite strain specificity, indicating that they were
directed against different antigens. Based on these findings, it
was hypothesized that immunodominance was a key factor in
determining the parasite strain specificity of immunity. The
results of antigen identification studies, which used polyclonal
CD8 T-cell lines from T. parva-immune animals of different
MHC genotypes to screen a schizont cDNA library and a set of
parasite genes selected by bioinformatic analyses, provided
further support for this idea. With one exception, T cells from
each animal identified only a single antigen, and T-cell lines
from animals of different MHC genotypes tended to identify
different antigens (10).
The present study set out to identify the epitopes recognized
in the T. parva antigens and to determine their MHC restric-
tion specificities, in order to facilitate further dissection of the
specificity of CD8 T-cell responses in immune cattle and to
allow the development of assays and tools, such as class I
tetramers, for monitoring the responses. Nine epitopes in six T.
FIG. 4. BoLA restriction of CD8 T-cell epitopes from defined T. parva antigens. The recognition of COS-7 cells transiently cotransfected with
CD8 T-cell target antigen cDNA and test BoLA cDNA or with CD8 T-cell target antigen cDNA and irrelevant BoLA cDNA or transfected with
test BoLA cDNA alone by antigen-specific cytotoxic T lymphocytes (those from animals BV115 [Tp1214–224], BW002 [Tp227–37], BW013 [Tp249–59],
D409 [Tp296–104], BW014 [Tp298–106], BX063 [Tp4328–336 and Tp8379–387], BV050 [Tp587–95], and BW012 [Tp7206–214]) was assessed using an IFN-
ELISPOT assay. The results of one of three independent experiments are shown. The data are the mean numbers of SFC/104 CD8 T cells 
standard errors of the means for triplicate cultures. Tx COS-7, COS-7 cell transfection.
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parva antigens, together with their respective MHC restriction
elements, were successfully identified. This report provides the
first description of CD8 T-cell epitopes and corresponding
MHC class I restriction elements in cattle. The epitopes, as
defined by the minimal peptide length that induced maximal
T-cell reactivity, were either 9-mers or 11-mers. In all but one
case, CD8 T cells derived from eight different animals recog-
nized only one of the six antigens. Single epitopes were iden-
tified in five of the six antigens; the epitopes in two of these
antigens (Tp4 and Tp8) were restricted by the same class I
allele, while those in the other three antigens (Tp1, Tp5, and
Tp7) were restricted by different class I alleles. The Tp2 anti-
gen was found to contain four epitopes, two of which were
restricted by the same MHC class I allele, while the other two
epitopes were restricted by different alleles.
The detection of responses to only one of the six antigens, in
many cases focused on a single epitope, supports previous
evidence that there is a dominance hierarchy in the antigens
recognized in CD8 T-cell responses to T. parva. Further studies
are needed to determine what proportion of the response in
individual immune animals is directed at these antigens in
order to provide quantitative data on the extent to which these
antigens dominate the response. Immunodominance in out-
bred populations is a well-described phenomenon for CD8
T-cell responses to viruses and cancer, in which the pool of
potential antigenic peptides is relatively small in comparison to
those in response to complex intracellular bacterial and pro-
tozoan pathogens. The screening of Plasmodium falciparum
and Mycobacterium tuberculosis for antigens and epitopes by
using CD8 T cells from immunized or exposed humans has
shown the recognition of a relatively large number of antigens,
rather than a narrow focus on a few immunodominant proteins
and epitopes (2, 18). The results of this and earlier studies (8,
19) suggest that immunodominance may play a much greater
role in the bovine CD8 T-cell response to T. parva than in
TABLE 2. Recognition of defined T. parva CD8 T-cell epitopes by cattle with defined BoLA types immunized by infection and treatment
Animal MHC class I serotypeb MHC class Irestricting allelec
Response to epitoped:
Tp1214–224 Tp249–59 Tp298–106 Tp4328–336 Tp8379–387
BV115 A10/A18 N*01301 
D232 A18/ N*01301 
633 A18/A14 N*01301 
468a A18 N*01301 
641a A18 N*01301 
BV115 A10/A18 N*01201  
BW013 A10/ N*01201  
BW014 A10/ N*01201  
592a A10 N*01201  
1011a A10 N*01201  
BX063a A10-KN104 N*00101  
BX064a A10-KN104 N*00101  
BX065a A10-KN104 N*00101  
BZ136 A10-KN104/ N*00101 
BZ143 A10-KN104/ N*00101 
BZ144 A10-KN104/ N*00101  
BZ145 A10-KN104/ N*00101 
a Homozygous for MHC serotype.
b A minus sign indicates that the MHC serotype is unknown.
c The restricting alleles N*01301, N*01201, and N*00101 are associated with the serotypes B. taurus A18, B. taurus A10, and B. indicus A10-KN104, respectively.
d CD8 T-cell responses to defined antigenic peptides were assessed by IFN- release and/or cytotoxicity, and plus signs indicate significant responses.
TABLE 3. Antigen specificity of CD8 T-cell IFN- responses





Specificity of response tob:
Tp1 Tp2 Tp4 Tp5 Tp8
N*01301 (A18) CP virus-MVA BZ027 
CP virus-MVA BZ039 






CP virus-MVA BX223  
CP virus-MVA BX216   
CP virus-MVA BX215  
DNA-MVA BX219   
DNA-MVA BX220 
DNA-MVA BX225   
T5 (undefined) CP virus-MVA BZ016  
CP virus-MVA BZ017  
CP virus-MVA BZ022 
DNA-MVA BZ019 
DNA-MVA BZ025  
DNA-MVA BZ013 
N*01201 (A10) CP virus-MVA BY142
CP virus-MVA BY206    
CP virus-MVA BZ026
DNA-MVA BY001  
DNA-MVA BY138
DNA-MVA BZ020
a Cattle were immunized with antigens Tp1, Tp2, Tp4, Tp5, and Tp8 by
using heterologous primer-booster regimes. Cattle were primed with either
recombinant CP virus or DNA vectors, and all received a booster immuni-
zation with recombinant MVA and then were challenged with a lethal dose of
sporozoites.
b The detection of a significant antigen-specific CD8 T-cell IFN- response,
as defined by the criteria described in Materials and Methods, is indicated by
a plus sign.
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the human CD8 T-cell response to pathogens of similar
complexity.
The present study provided evidence that T. parva-immune
cattle carrying defined MHC class I alleles consistently re-
spond to the epitopes corresponding to the respective MHC
backgrounds. Animals homozygous or heterozygous for B. tau-
rus A18 or A10 and B. indicus A10-KN104, which were shown
to recognize five epitopes in the Tp1, Tp2, Tp4, and Tp8
antigens, were available for these studies. Responses to the
single epitope defined in Tp1 and the two epitopes in Tp2 were
consistently detected in all of the B. taurus A18 and A10
animals, respectively. Responses to the epitope in Tp8 were
also observed in all seven B. indicus A10-KN104 animals, but
only four of these animals responded to the epitope in Tp4.
These findings indicate that the Tp1, Tp2, and Tp8 epitopes
are dominant in animals with these MHC genotypes. The vari-
able responses to Tp4328–336 suggest that this is a less-dominant
epitope; the failure to detect responses in three animals that
were heterozygous for the class I restriction element may have
been due to the presence of competing dominant epitopes
presented via the other MHC haplotype expressed by these
animals.
Despite the finding that animals of selected MHC genotypes
immunized with live parasites had significant CD8 T-cell re-
sponses to only one or, in the case of BoLA allele N*00101
animals, to one or two of the six antigens, most of the antigens
are likely to contain peptides capable of being presented by
cells of the different genotypes. Studies of murine and human
systems have provided evidence that the relative dominance of
particular epitopes can be influenced by a number of factors,
including the abundance of processed peptide, the binding
affinity of the peptides for the MHC, and the T-cell receptor
repertoire (23). The presentation of the different epitopes by
the same antigen-presenting cell, i.e., by dedicated antigen-
presenting cells following cross-priming or by the parasitized
cells themselves, may favor the preferential generation of re-
sponses to the most dominant antigens by allowing competi-
tion for epitope recognition by T cells. We therefore examined
whether or not the dominance of responses to the preferred
antigens was retained in animals immunized with five of the
antigens incorporated individually into different vaccine con-
structs. Responses against pools of synthetic peptides spanning
entire antigens were measured in order to assess the breadth of
the responses. Nineteen of 24 vaccinated animals mounted a
CD8 T-cell response, and in all instances, the dominant re-
sponse was directed against the antigen(s) that was predicted
based on the expression of the relevant MHC restriction ele-
ment. For 11 of the animals, the responses were directed solely
against these antigens. Although the assay employed did not
allow the target epitopes to be identified, the recognition of the
defined epitopes by cattle of the respective MHC genotypes
was confirmed for a small number of animals (S. P. Graham,
unpublished data). The absence of significant responses to
many of the antigens in most animals may reflect a lack of
potency of the vaccination protocols rather than an inability of
the animals to respond to the antigens. Nevertheless, the find-
ings clearly demonstrate that the preferred antigens are inher-
ently dominant in animals with the respective MHC genotypes.
They also suggest that the preferential induction of responses
to particular antigens is not due solely to competition for
presentation within antigen-presenting cells but rather may
reflect the presence within the T-cell repertoire of T cells with
high-avidity receptors for the respective epitopes.
The results of these studies are of particular practical sig-
nificance because of the well-documented antigenic variability
among strains of T. parva, which results in incomplete cross-
protection against different strains (17). Additional prelimi-
nary studies of the antigens described herein have confirmed
that the defined epitope regions vary in sequence among par-
asite strains and are differentially recognized by CD8 T cells
(R. Pelle´ and S. P. Graham, unpublished data). Hence, a major
challenge in the development of a vaccine based on the induc-
tion of CD8 T-cell responses will be to generate responses that
are effective against all parasite strains. Further studies are
required to provide a more comprehensive picture of the an-
tigen recognition capacity of animals of different MHC geno-
types to ascertain whether combinations of antigens that po-
tentially provide broad protection can be identified and used to
induce protective CD8 T-cell responses.
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